Icure Pharmaceutical Inc. engages in the development and manufacture of transdermal drug delivery system. It operates through the pharmaceutical and cosmeceutical business. The pharmaceutical business provides specialized and over-the-counter medical products such as anesthetic drugs, anticonvulsant, mixed vitamin pills, fever reducer, anti-inflammatory drugs, painkiller and others. The cosmeceutical business offers skin care, hair care and body products such as skin lotion, cream, cleanser, shampoo, hair essence, hand cream, mask and others. The company was founded on May 29, 2000 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company